Use of aminoglycosides in immunocompromised patients
- 15 July 1985
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 79 (1) , 21-27
- https://doi.org/10.1016/0002-9343(85)90187-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The Clinical Challenge of Infections Due to Pseudomonas aeruginosaClinical Infectious Diseases, 1984
- Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infectionsAntimicrobial Agents and Chemotherapy, 1983
- Emergence of Resistance During Therapy with the Newer -Lactam Antibiotics: Role of Inducible -Lactamases and Implications for the FutureClinical Infectious Diseases, 1983
- Problems in Determining the Efficacy of AminoglycosidesClinical Infectious Diseases, 1983
- Postantibiotic Suppression of Bacterial GrowthClinical Infectious Diseases, 1981
- Improved prognosis for granulocytopenic patients with gram-negative bacteremiaThe American Journal of Medicine, 1980
- The Recovery Period following Exposure of Bacteria to PenicillinsChemotherapy, 1979
- Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patientsThe American Journal of Medicine, 1977
- Persistent Effect of Antibiotics on Staphylococcus aureus after Exposure for Limited Periods of TimeThe Journal of Infectious Diseases, 1977
- Amikacin therapy of infections in neutropenic patientsThe Lancet Healthy Longevity, 1975